What are the differences between laryngospasm and bronchospasm in terms of presentation, pathophysiology, and emergency management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laryngospasm vs Bronchospasm: Key Differences and Management

Laryngospasm and bronchospasm are fundamentally different airway emergencies that occur at distinct anatomical locations—laryngospasm involves persistent vocal cord apposition at the glottic level, while bronchospasm represents lower airway smooth muscle constriction—and they require completely different emergency management approaches.

Anatomical Location and Pathophysiology

Laryngospasm occurs at the upper airway (vocal cords/glottis) and represents an exaggerated protective reflex involving persistent apposition of the vocal cords 1. The mechanism involves stimulation of the superior laryngeal nerve, resulting in complete or partial glottic closure 1.

Bronchospasm occurs in the lower airway (bronchioles) and represents smooth muscle constriction of the bronchial tree 1. It is the lower airway equivalent response to irritation 1.

Clinical Presentation

Laryngospasm Presentation:

  • Early/partial obstruction: Characteristic inspiratory "crowing" sound (stridor) 1
  • Progressive obstruction: Marked suprasternal recession ("tracheal tug"), use of accessory respiratory muscles, paradoxical chest/abdominal movements 1
  • Complete obstruction: Silent inspiration (no air movement despite respiratory effort) 1
  • Incidence: 8.7 per 1000 patients overall; higher in children, smokers, patients with airway infections 1

Bronchospasm Presentation:

  • Wheezing (expiratory predominant)
  • Prolonged expiratory phase
  • Increased work of breathing
  • High airway pressures during ventilation
  • Chest tightness
  • Incidence in pediatric adenotonsillectomy: 1.8% 2

Emergency Management

Laryngospasm Management Algorithm 1:

  1. Call for help immediately

  2. Apply 100% oxygen with CPAP via reservoir bag and facemask while ensuring upper airway patency. Avoid unnecessary airway stimulation

  3. Larson's manoeuvre: Place middle finger of each hand in the "laryngospasm notch" (between posterior mandible and mastoid process) while performing jaw thrust with deep pressure

  4. If laryngospasm persists or oxygen saturation falling:

    • Propofol 1-2 mg/kg IV
    • Low doses effective for early laryngospasm
    • Larger doses needed for severe laryngospasm or total cord closure
  5. If worsening hypoxia with continuing severe laryngospasm:

    • Succinylcholine 1 mg/kg IV (provides cord relaxation for ventilation, re-oxygenation, and intubation if necessary)
    • Without IV access: IM (2-4 mg/kg), intralingual (2-4 mg/kg), or intraosseous (1 mg/kg) routes 1
  6. Atropine may be required for bradycardia

  7. In extremis: Consider surgical airway 1

Bronchospasm Management:

  • Inhaled beta-agonists (albuterol/salbutamol) - primary treatment 2, 3
  • Deepen inhalational anesthesia (sevoflurane preferred) 4
  • IV lidocaine 4
  • Systemic corticosteroids for moderate-severe cases 3
  • Inhaled anticholinergics (ipratropium) 3
  • Optimize ventilation parameters
  • Consider other causes if refractory 5

Critical Complications

Laryngospasm-Specific:

Post-obstructive pulmonary edema is the most important complication, occurring in >50% of post-obstructive pulmonary edema cases 1. This develops from:

  • Forceful inspiratory efforts against closed glottis creating extreme negative intrathoracic pressure
  • Increased pulmonary capillary hydrostatic pressure gradient
  • Fluid leak into interstitium
  • Presents with dyspnea, agitation, cough, pink frothy sputum, low oxygen saturations 1
  • More common in young muscular adults (male:female ratio 4:1) 1
  • Usually resolves within hours with prompt treatment 1

Hypoxic cardiac arrest and death can occur if laryngospasm is unrelieved 1

Bronchospasm-Specific:

  • Severe hypoxemia
  • Respiratory failure requiring intubation
  • Barotrauma from high airway pressures
  • Cardiac arrest in severe cases 6

Risk Factors

Laryngospasm:

  • Extubation during light plane of anesthesia (highest risk) 1
  • Children 1, 2
  • Smokers 1
  • Pre-existing airway infections 1
  • Blood, secretions, or surgical debris in airway 1
  • Specific anesthetic agents (volatile agents more irritant than propofol/sevoflurane) 1

Bronchospasm:

  • Underlying asthma (significantly increased risk) 2
  • Reactive airway disease
  • Recent upper respiratory infection
  • Smoking history
  • Allergic reactions 7

Prevention Strategies

Laryngospasm Prevention 1:

  • Extubate either deeply anesthetized OR fully awake—avoid the "in-between" stage
  • Suction under direct vision while deeply anesthetized
  • Avoid stimulation until patient fully awake
  • Topical lidocaine on vocal cords at induction
  • Use propofol-based or sevoflurane anesthesia (least irritant) 1
  • Consider IV lidocaine, magnesium, or ketamine 1

Bronchospasm Prevention:

  • Optimize asthma control preoperatively
  • Pretreatment with bronchodilators in at-risk patients
  • Avoid airway irritation
  • Adequate depth of anesthesia 8

Common Pitfalls

  1. Mistaking complete laryngospasm for apnea: Silent inspiration with chest wall movement indicates complete obstruction, not central apnea 1

  2. Delaying succinylcholine in severe laryngospasm: Persistent attempts at conservative management when hypoxia is worsening increases risk of cardiac arrest 1

  3. Inadequate propofol dosing: Low doses work for early laryngospasm, but severe cases require higher doses (up to 2 mg/kg) 1

  4. Confusing the two conditions: Laryngospasm presents with stridor or silence; bronchospasm presents with wheezing 5

  5. Undertreating pediatric bronchospasm: Pediatric patients are significantly less likely to receive appropriate interventions including beta-agonists and corticosteroids 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.